
1001 - 5000 employees
Founded 2003
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative medicines that address serious unmet medical needs. With a strong commitment to research and development, Jazz focuses on creating life-changing therapies, emphasizing the importance of collaboration, diversity, and employee engagement in its operations. The company prides itself on transforming patients' lives through its meaningful product offerings and a culture that fosters enthusiasm and flexibility.
🔥 0 minutes ago
🌐 United States, United Kingdom – Remote
🏄 California, Pennsylvania – Remote
💵 $212k - $318k / year
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
👻 Ghost score 0%
Where this job comes from
Posted on Jazz Pharmaceuticals's careers page, not through a job board
First seen by Remote Rocketship 0 minutes ago

1001 - 5000 employees
Founded 2003
🏥 Healthcare
🏭 Manufacturing
🧬 Biotechnology
Healthcare • Manufacturing • Biotechnology
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative medicines that address serious unmet medical needs. With a strong commitment to research and development, Jazz focuses on creating life-changing therapies, emphasizing the importance of collaboration, diversity, and employee engagement in its operations. The company prides itself on transforming patients' lives through its meaningful product offerings and a culture that fosters enthusiasm and flexibility.
• Define and execute global and US payer evidence strategies in Oncology • Lead global HEOR activities and strategies in gastroesophageal adenocarcinoma and prepare assets for commercial and reimbursement milestones worldwide • Serve as lead HEOR partner for an Oncology asset’s expanding clinical pipeline and embed payer and HTA requirements into Phase 2 and Phase 3 programs • Serve as designated US HEOR lead, translating access and reimbursement priorities into evidence strategies supporting commercial, Medicare, and Medicaid access • Execute and author AMCP dossiers, US commercial/Medicare budget impact models, and state Medicaid submission packages • Partner with US Payer Field Teams to develop customer-facing economic models, slide decks, and digital tools • Monitor US health policy and prepare evidence roadmaps for value assessments such as ICER reviews and NCCN Evidence Blocks • Collaborate on innovative payment models and value-based contracts • Integrate payer, HTA, and reimbursement evidence requirements into clinical trial protocols • Optimize trial protocols, comparators, inclusion/exclusion criteria, lines of therapy, and payer-recognized endpoints • Integrate PROs, HRQoL, and HCRU measures into pivotal trials • Develop rare disease evidence strategies addressing small samples, heterogeneous presentations, single-arm studies, and surrogate endpoints • Formulate and execute health economic modeling strategies, including CEA, CUA, and BIM • Design and validate adaptable global core economic models for EU/INT HTA submissions and US payer use • Lead global payer evidence assets, including GVDs, SLRs, and global evidence libraries • Co-deliver HTA evidence packages, including ITCs, NMAs, and economic model adaptations, with the EU/INT HEOR team • Design and deliver RWE, natural history, burden-of-illness, treatment-pattern, and comparative-effectiveness studies • Lead HEOR launch readiness, lifecycle management, label expansion, and post-launch evidence programs • Govern IEGP HEOR commitments and align evidence plans with Market Access, Brand Teams, and Medical Affairs • Lead publication strategy, author peer-reviewed manuscripts, and present at scientific and health economic congresses • Mentor junior scientists, cross-functional colleagues, and HEOR fellows • Ensure evidence generation and communications comply with legal, regulatory, and corporate standards
• Required Master’s degree (MSc, MS, MPH, PhD) in Health Economics, Outcomes Research, Pharmacoeconomics, or a closely related quantitative field • Minimum of 7–10 years of experience in HEOR, Global Value, or Health Economics within the biopharmaceutical industry or a top-tier HEOR consulting firm • Deep working knowledge of US managed care archetypes, including commercial health plans, PBMs, Medicare Part B/D, and Medicaid • Thorough familiarity with US payer communication compliance standards, including FDAMA Section 114 and the 21st Century Cures Act • Advanced expertise in health economic modeling, including Markov state-transition models, partitioned survival models, microsimulation, and discrete event simulation • Demonstrated track record partnering with US Payer Field Teams to develop interactive economic models and value presentation tools • Practical understanding of rare disease evidence generation challenges, including small patient samples, registry utilization, natural history studies, external control arms, and orphan drug HTA mechanisms • Proven track record leading HEOR workstreams for global and US launch preparation, lifecycle management, label expansions, and value defense • Demonstrated experience collaborating with Clinical Development and Biostatistics teams on Phase 2/3 study designs, comparator selection, and HEOR/PRO endpoints • Strong understanding of US health policy developments and experience preparing for or responding to value assessment bodies such as ICER • Proven ability to set global and US evidence strategies while directly executing complex deliverables such as AMCP dossiers, GVDs, NMAs, economic models, and RWE protocols • Ability to lead and collaborate cross-functionally across Clinical Development, Medical Affairs, Market Access, Regulatory, and Commercial without formal authority • Experience managing multi-million-dollar research budgets, vendor selection, and external CROs and academic partners • Experience with oncology assets preferred • Launch lead for at least 2 assets as US HEOR lead or country-level HTA lead • Strong peer-reviewed publication record in health economics and outcomes research
• Discretionary annual cash bonus or incentive compensation • Discretionary equity grants • Medical insurance • Dental insurance • Vision insurance • 401k retirement savings plan • Flexible paid vacation
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🔥 5 minutes ago
Product Delivery Director guiding Voya’s Employee Benefits technology roadmap and delivery. Leading prioritization, readiness, testing, adoption, and stakeholder alignment for financial-services solutions.
🔥 1 hour ago
Pfizer director translating specialty-care patient engagement strategy into compliant GTM plans, targeting models, and field execution. Driving launches, analytics, governance, and cross-functional enablement.
🇺🇸 United States – Remote
💵 $176.6k - $294.3k / year
💰 Post-IPO Debt on 2023-05
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
🔥 1 hour ago
Director leading Palo Alto Networks’ NGFW and SASE growth through MSP, MSSP, and GSI partnerships. Building offerings, routes to market, and partner-led pipeline.
🇺🇸 United States – Remote
💵 $273.6k - $319.2k / year
💰 $1M Seed Round - Morta Security on 2013-02
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
🔥 2 hours ago
WelbeHealth IT director leading enterprise technology portfolios, governance, and delivery. Aligning investments, budgets, and delivery practices to improve care for vulnerable seniors.
🇺🇸 United States – Remote
💵 $159.9k - $211.1k / year
💰 $30M Series C on 2020-02
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
🔥 2 hours ago
RCM director launching Practice by Numbers’ dental revenue cycle business. Building US and India teams, workflows, client services and revenue growth operations.